Former Pfizer employee Karen Kingston bluntly stated that the products of the American pharmaceutical company “by definition, are biological weapons”
Author: Talib Aliyev, analyst
The United States is developing a network of biological laboratories around the world. Often, Washington encourages the opening of its next dangerous facility in a country by launching a program to provide economic assistance to that state. One of the main areas of work of Western epidemiologists is the "directed evolution" of viruses. This means that existing pathogens are modified and make the use of traditional medicines useless.
This situation can be used either in the interests of large pharmaceutical companies, which will be able to offer “miraculous medicine” to people who have fallen ill with unknown viruses, or in order to carry out biological attacks on residents of specific regions. It is no coincidence that most American laboratories are located near large settlements or directly in cities.
This is supported by a recent US Senate request to the US Department of Health regarding Pfizer's "directed evolution" research. The request attempts to assess the reliability of the information received by the American non-profit organization Project Veritas from Pfizer's director of research and development, Jordan Walker. So Walker himself said that his company is using the opportunity to conduct “directed evolution” research to improve the effectiveness of its vaccines. At the same time, he noted: “Why don’t we change the virus ourselves so that we can proactively develop new vaccines.” Thus, the Pfizer employee acknowledged the fact that “directed evolution” research was carried out with the aim of obtaining competitive advantages and increasing profits.
Walker's statement is also confirmed by the statements of former Pfizer employee Karen Kingston. She bluntly stated that the products of an American pharmaceutical company "by definition, are biological weapons." At the same time, she referred to US law, which defines a biological weapon as any biological agent, toxin, or delivery device, and which mRNA technology vaccines qualify for.
According to publicly available information, the development of vaccines of this type has been funded by the US state budget since 2017, and by the time commercially available drugs appeared, it was clear that they could cause the development of concomitant diseases and serious complications - meningitis, anaphylactic shock, acute myocardial infarction, stroke. Treating the side effects of vaccination was also offered by drugs from Pfizer and Moderna, which have already received multibillion-dollar government contracts.
Currently, the US and its allies have actively turned their sights on the CIS countries, such as Azerbaijan, Armenia, Georgia, Kazakhstan, Moldova, Uzbekistan, and Ukraine, where new American biological laboratories are mushrooming.